Co-amplification of luminol-based electrochemiluminescence immunosensors based on multiple enzyme catalysis of bimetallic oxides CoCeOx and NiMnO3 for the detection of CYFRA21-1-Reference-Cited by-同舟云学术

Co-amplification of luminol-based electrochemiluminescence immunosensors based on multiple enzyme catalysis of bimetallic oxides CoCeO_x and NiMnO₃ for the detection of CYFRA21-1

Published:2023 Issue:14 Volume:148 Page:3371-3378
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Zhang Jingjing¹,Li Min¹,Fang Jinglong¹,Wang Caihong²,Liu Lei¹,Cao Wei¹^ORCID,Wei Qin¹³^ORCID

Affiliation:

1. Key Laboratory of Interfacial Reaction & Sensing Analysis in Universities of Shandong, School of Chemistry and Chemical Engineering, University of Jinan, Jinan 250022, PR China

2. Department of Chemical Engineering and Safety, Binzhou University, Binzhou 256600, China

3. Department of Chemistry, Sungkyunkwan University, Suwon, 16419, Republic of Korea

Abstract

Accelerated energy supply of co-reactants is an extremely effective strategy for achieving highly sensitive electrochemiluminescence analysis, and binary metal oxides would be an excellent tool for this purpose due to the mixed metal valence states.

Funder

Natural Science Fund for Distinguished Young Scholars of Shandong Province

National Natural Science Foundation of China

National Key Scientific Instrument and Equipment Development Projects of China

Natural Science Foundation of Shandong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/AN/D3AN00753G

Reference34 articles.

1. Early detection of lung cancer biomarkers through biosensor technology: A review

2. A Novel Signal‐On Electrochemiluminescence Immunosensor for the Detection of NSCLC Antigen Biomarker Based on New Co‐Reaction Accelerators

3. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

4. P2.01-067 The Relevance of CEA and CYFRA21-1 as Predictive Factors in Nivolumab Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

5. Liposome encapsulated electron donor strategy for signal-on CYFRA 21-1 photoelectrochemical analysis